Business & Regulation

With an EMA pilot scheme underway it looks likely that adaptive licensing will feature in the future drug development landscape.

Hiring gifted new employees is tough enough, but how do you keep them within your organization once you’ve got them?

New Alzheimer’s treatment gets $500 million collaborative boost

Opportunistic investors surf the wave of experimental treatments

Merck KGaA snaps up Sigma-Aldrich, Allergan fights Valeant, and Shire–Abbvie deal sours

Antibiotics were once hailed as wonder drugs in the war against infection, but now it looks like bacteria might have the upper hand. How can we turn the tide?

An FDA Warning Letter can be a real wake up call. How can you address the root of the problem?

Sitting Down With… Wim Leereveld, founder and CEO of the Access to Medicine Foundation

The World Health Organization has compiled a list of 17 tropical diseases that deserve higher priority.

After years of intense criticism, the European Parliament has adopted a new regulation for clinical trials that will replace the current EU Clinical Trials Directive by mid-2016.